High-risk Prostate Cancer trials recruiting in New York

All High-risk Prostate Cancer trials nationally

Cities in New York

Recruiting trials in New York

• A Single-Arm Phase II Study of Neoadjuvant Intensified Androgen Deprivation (Leuprolide and Abiraterone Acetate) in Combination With AKT Inhibition (Capivasertib) for High-Risk Localized Prostate Cancer With PTEN Loss
  NCT05593497 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · New York: The Bronx
• Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
  NCT07027124 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · New York: New York
• Radiation Therapy Approaches for People With Prostate Cancer
  NCT07751159 · Phase: Phase 2 · Ages: No age limits stated · Sex: All (male and female) · New York: Commack, Harrison, New York, Uniondale